Rocket Lab Corporation $RKLB Position Trimmed by Prime Capital Investment Advisors LLC

Prime Capital Investment Advisors LLC reduced its holdings in shares of Rocket Lab Corporation (NASDAQ:RKLB) by 7.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 153,530 shares of the rocket manufacturer’s stock after selling 13,158 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Rocket Lab were worth $10,698,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of Rocket Lab in the second quarter valued at about $4,124,970,000. Bank of America Corp DE acquired a new stake in shares of Rocket Lab during the second quarter worth about $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Rocket Lab by 14.8% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer’s stock worth $278,262,000 after buying an additional 352,094 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Rocket Lab during the second quarter worth about $245,764,000. Finally, Amundi grew its holdings in shares of Rocket Lab by 22.2% during the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer’s stock worth $221,673,000 after buying an additional 396,639 shares during the last quarter. 71.78% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Rocket Lab in a research report on Thursday, October 15th. Needham & Company LLC reaffirmed a “buy” rating and set a $120.00 price objective on shares of Rocket Lab in a research report on Friday. KeyCorp lowered their target price on Rocket Lab from $135.00 to $100.00 and set an “overweight” rating on the stock in a research note on Thursday, October 15th. Roth Capital reiterated a “buy” rating on shares of Rocket Lab in a research note on Thursday, October 15th. Finally, Citizens Jmp dropped their target price on Rocket Lab from $130.00 to $90.00 and set a “market outperform” rating on the stock in a report on Friday, October 16th. Three analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $102.05.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab’s backlog has reportedly reached approximately $2.3 billion, up 137% year over year, supported by agreements including missile-defense satellite work for the U.S. Space Force. The backlog and ongoing Electron launch activity offer revenue visibility while Neutron development continues. Why Rocket Lab’s Recent Fall Is Overblown
• Positive Sentiment: Cantor Fitzgerald maintained an Overweight rating and its $122 price target, arguing that the recent selloff may be excessive despite the Neutron setback. Rocket Lab Stock Drops Today, but Cantor Fitzgerald Sticks to $122 Price Target
• Neutral Sentiment: Rocket Lab will release third-quarter 2026 results after the market close on November 9 and hold a conference call afterward. The announcement itself does not change financial expectations but gives investors a near-term earnings catalyst. Rocket Lab Announces Date of Third Quarter 2026 Financial Results
• Negative Sentiment: Rocket Lab postponed Neutron’s inaugural launch to 2027 after identifying manufacturing and structural problems in key propellant tanks. The company is redesigning parts of the first stage and manufacturing a replacement forward dome, delaying potential higher-value launch revenue and increasing execution risk. Does Neutron Delay Change the Bull Case for Rocket Lab?
• Negative Sentiment: The delay has intensified concerns about valuation, cash-flow timing and management’s ability to deliver Neutron, leading to sharply weaker investor sentiment. Rocket Lab’s existing Electron business and backlog now bear more responsibility for supporting growth until Neutron becomes operational. Rocket Lab’s Biggest Technological Advantage Is Fast Becoming Its Biggest Problem

Insider Activity

In other Rocket Lab news, CFO Adam C. Spice sold 140,157 shares of Rocket Lab stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $70.82, for a total value of $9,925,918.74. Following the sale, the chief financial officer owned 1,155,967 shares of the company’s stock, valued at approximately $81,865,582.94. The trade was a 10.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Agostino Ricupati sold 669 shares of Rocket Lab stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $46,582.47. Following the completion of the sale, the chief accounting officer directly owned 26,863 shares in the company, valued at $1,870,470.69. This represents a 2.43% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 400,749 shares of company stock valued at $26,964,474 over the last ninety days. 8.40% of the stock is currently owned by company insiders.

Rocket Lab Trading Down 0.9%

Shares of Rocket Lab stock opened at $50.90 on Wednesday. Rocket Lab Corporation has a one year low of $37.57 and a one year high of $151.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The firm has a fifty day moving average of $67.70 and a two-hundred day moving average of $84.05.

Rocket Lab (NASDAQ:RKLB) last issued its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to analysts’ expectations of $231.62 million. As a group, equities research analysts forecast that Rocket Lab Corporation will post -0.20 EPS for the current fiscal year.

Rocket Lab Profile

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.